(Q40622910)

22 September 2017

Pituitary adenylate cyclase-activating polypeptide inhibits cutaneous immune function (English)

1 reference

22 September 2017

Pituitary adenylate cyclase‐activating polypeptide inhibits cutaneous immune function (English)

1 reference

https://api.crossref.org/works/10.1002/EJI.200324085

25 March 2024

1 reference

1 reference

https://api.crossref.org/works/10.1002/EJI.200324085

25 March 2024

author name string

Sreedevi Kodali

1

1 reference

22 September 2017

Ilyse Friedman

2

1 reference

22 September 2017

Wanhong Ding

3

1 reference

22 September 2017

Kristina Seiffert

4

1 reference

22 September 2017

John A. Wagner

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14579275

25 March 2024

Richard D. Granstein

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14579275

25 March 2024

language of work or name

English

0 references

publication date

1 November 2003

1 reference

full work available at URL

22 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Feji.200324085

1 reference

https://api.crossref.org/works/10.1002/EJI.200324085

https://onlinelibrary.wiley.com/doi/pdf/10.1002/eji.200324085

25 March 2024

1 reference

https://api.crossref.org/works/10.1002/EJI.200324085

European Journal of Immunology

25 March 2024

published in

1 reference

22 September 2017

33

1 reference

22 September 2017

11

1 reference

22 September 2017

3070-3079

1 reference

Immune functions of the human skin. Models of in vitro studies using Langerhans cells

22 September 2017

1

1 reference

https://api.crossref.org/works/10.1002/EJI.200324085

Epidermal Langerhans' cells and their function in the skin immune system.

25 March 2024

2

1 reference

https://api.crossref.org/works/10.1002/EJI.200324085

Regulation of Langerhans cell function by nerves containing calcitonin gene-related peptide

25 March 2024

3

1 reference

https://api.crossref.org/works/10.1002/EJI.200324085

Regulation of cytokine expression in macrophages and the Langerhans cell-like line XS52 by calcitonin gene-related peptide.

25 March 2024

4

1 reference

https://api.crossref.org/works/10.1002/EJI.200324085

A substance p agonist acts as an adjuvant to promote hapten-specific skin immunity

25 March 2024

8

1 reference

https://api.crossref.org/works/10.1002/EJI.200324085

Substance P induction of murine keratinocyte PAM 212 interleukin 1 production is mediated by the neurokinin 2 receptor (NK-2R).

25 March 2024

9

1 reference

https://api.crossref.org/works/10.1002/EJI.200324085

Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells

25 March 2024

10

1 reference

https://api.crossref.org/works/10.1002/EJI.200324085

Pituitary adenylate cyclase activating polypeptide (PACAP) is localized in human dermal neurons and causes histamine release from skin mast cells

25 March 2024

12

1 reference

https://api.crossref.org/works/10.1002/EJI.200324085

Expression of neurotrophic factors and neuropeptide receptors by Langerhans cells and the Langerhans cell-like cell line XS52: further support for a functional relationship between Langerhans cells and epidermal nerves

25 March 2024

13

1 reference

https://api.crossref.org/works/10.1002/EJI.200324085

VIP and PACAP38 modulate cytokine and nitric oxide production in peritoneal macrophages and macrophage cell lines

25 March 2024

14

1 reference

https://api.crossref.org/works/10.1002/EJI.200324085

Differential production of interferon-γ and interleukin-4 in response to Th1- and Th2-stimulating pathogens by γδ T cells in vivo

25 March 2024

16

1 reference

https://api.crossref.org/works/10.1002/EJI.200324085

Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit LPS-stimulated MIP-1alpha production and mRNA expression.

25 March 2024

17

1 reference

https://api.crossref.org/works/10.1002/EJI.200324085

Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro

25 March 2024

19

1 reference

https://api.crossref.org/works/10.1002/EJI.200324085

Role of cytokines in epidermal Langerhans cell migration

25 March 2024

22

1 reference

https://api.crossref.org/works/10.1002/EJI.200324085

Cytokine expression by epidermal cell subpopulations

25 March 2024

26

1 reference

https://api.crossref.org/works/10.1002/EJI.200324085

Stimulation of Langerhans cell migration in mice by tumour necrosis factor alpha and interleukin 1 beta

25 March 2024

27

1 reference

https://api.crossref.org/works/10.1002/EJI.200324085

Interleukin-1 beta and granulocyte-macrophage colony-stimulating factor mediate Langerhans cell maturation differently

25 March 2024

28

1 reference

https://api.crossref.org/works/10.1002/EJI.200324085

Interaction of IL-1 beta, IL-6 and tumour necrosis factor-alpha (TNF-alpha) in human T cells activated by murine antigens

25 March 2024

29

1 reference

https://api.crossref.org/works/10.1002/EJI.200324085

IL-10 inhibits ICAM-1 expression on human Langerhans cells but not on keratinocytes, dermal endothelial cells or fibroblasts

25 March 2024

31

1 reference

https://api.crossref.org/works/10.1002/EJI.200324085

Comparative analysis of CD80 and CD86 on human Langerhans cells: expression and function

25 March 2024

32

1 reference

https://api.crossref.org/works/10.1002/EJI.200324085

Blocking the CD80 and CD86 costimulation molecules: lessons to be learned from animal models

25 March 2024

33

1 reference

https://api.crossref.org/works/10.1002/EJI.200324085

Expression and function of B7-1 (CD80) and B7-2 (CD86) on human epidermal Langerhans cells

25 March 2024

34

1 reference

https://api.crossref.org/works/10.1002/EJI.200324085

Expression and function of B7-1 and B7-2 in hapten-induced contact sensitivity

25 March 2024

35

1 reference

https://api.crossref.org/works/10.1002/EJI.200324085

The differential role of CD86 and CD80 co-stimulatory molecules in the induction and the effector phases of contact hypersensitivity

25 March 2024

36

1 reference

https://api.crossref.org/works/10.1002/EJI.200324085

VIP and PACAP inhibit IL-12 production in LPS-stimulated macrophages. Subsequent effect on IFNgamma synthesis by T cells

25 March 2024

37

1 reference

https://api.crossref.org/works/10.1002/EJI.200324085

Inhibition of endotoxin-induced macrophage chemokine production by VIP and PACAP in vitro and in vivo

25 March 2024

40

1 reference

https://api.crossref.org/works/10.1002/EJI.200324085

Reduction of lipopolysaccharide-induced neurotoxicity in mixed cortical neuron/glia cultures by femtomolar concentrations of pituitary adenylate cyclase-activating polypeptide.

25 March 2024

42

1 reference

https://api.crossref.org/works/10.1002/EJI.200324085

Anti-inflammatory role in septic shock of pituitary adenylate cyclase-activating polypeptide receptor.

25 March 2024

43

1 reference

https://api.crossref.org/works/10.1002/EJI.200324085

Enhanced delayed-type hypersensitivity and diminished immediate-type hypersensitivity in mice lacking the inducible VPAC(2) receptor for vasoactive intestinal peptide.

25 March 2024

44

1 reference

https://api.crossref.org/works/10.1002/EJI.200324085

Pituitary adenylate cyclase-activating polypeptide and islet amyloid polypeptide in primary sensory neurons: functional implications from plasticity in expression on nerve injury and inflammation.

25 March 2024

45

1 reference

https://api.crossref.org/works/10.1002/EJI.200324085

Pituitary adenylate cyclase-activating peptide (PACAP) immunolocalization in lymphoid tissues of the rat

25 March 2024

46

1 reference

https://api.crossref.org/works/10.1002/EJI.200324085

Modulation of adrenal catecholamine release by PACAP in vivo

25 March 2024

47

1 reference

https://api.crossref.org/works/10.1002/EJI.200324085

Catecholamines inhibit the antigen-presenting capability of epidermal Langerhans cells

25 March 2024

48

1 reference

https://api.crossref.org/works/10.1002/EJI.200324085

Pituitary adenylate cyclase-activating polypeptide inhibits collagen-induced arthritis: an experimental immunomodulatory therapy

25 March 2024

49

1 reference

https://api.crossref.org/works/10.1002/EJI.200324085

A potent and highly selective VPAC2 agonist enhances glucose-induced insulin release and glucose disposal: a potential therapy for type 2 diabetes

25 March 2024

50

1 reference

https://api.crossref.org/works/10.1002/EJI.200324085

Structural requirements for the occupancy of pituitary adenylate-cyclase-activating-peptide (PACAP) receptors and adenylate cyclase activation in human neuroblastoma NB-OK-1 cell membranes. Discovery of PACAP(6-38) as a potent antagonist

25 March 2024

51

1 reference

https://api.crossref.org/works/10.1002/EJI.200324085

Cytokine-dependent regulation of growth and maturation in murine epidermal dendritic cell lines

25 March 2024

53

1 reference

https://api.crossref.org/works/10.1002/EJI.200324085

Regulation of the immune response to tumor antigen. VI. Differential specificities of suppressor T cells or their products and effector T cells

25 March 2024

55

1 reference

https://api.crossref.org/works/10.1002/EJI.200324085

25 March 2024

Identifiers

1 reference

22 September 2017

1 reference